KLTO — Klotho Neurosciences Cashflow Statement
0.000.00%
Last trade - 00:00- $4.98m
- $5.19m
Annual cashflow statement for Klotho Neurosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.004 | 1.23 | 1.35 | -6.15 |
| Deferred Taxes | ||||
| Non-Cash Items | 0.009 | -1.97 | -2.83 | 2.34 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | — | 0.164 | 0.281 | 0.86 |
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 0.005 | -0.493 | -1.26 | -2.95 |
| Other Investing Cash Flow Items | — | -116 | 102 | -0.123 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | — | -116 | 102 | -0.123 |
| Financing Cash Flow Items | — | -3.35 | -102 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0 | 117 | -101 | 3.13 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.005 | 0.336 | -0.168 | 0.061 |